Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Jo

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Genes, Chromosomes & Cancer|November 10, 2017
Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgeryYue Hu, Jochen Gaedcke, Georg Emons, et al.
International Journal of Molecular Sciences|April 20, 2016
Prognostic Value of MicroRNAs in Preoperative Treated Rectal CancerAzadeh Azizian, Ingo Epping, Frank Kramer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2009
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapyJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Genes, Chromosomes & Cancer|August 21, 2010
Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomasJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 13, 2013
Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7gJunius Salendo, Melanie Spitzner, Frank Kramer, et al.
International Journal of Cancer|September 27, 2012
Molecular patterns in the evolution of serrated lesion of the colorectumTimo Gaiser, Sandra Meinhardt, Daniela Hirsch, et al.
Annals of Surgical Oncology|February 25, 2011
Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatmentLena-Christin Conradi, Annalen Bleckmann, Markus Schirmer, et al.
Plos One|October 1, 2020
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancerPeter Jo, Markus Bernhardt, Manuel Nietert, et al.
Plos One|April 12, 2016
Heterogeneity of KRAS Mutation Status in Rectal CancerPeter Jo, Alexander König, Markus Schirmer, et al.
Surgery|October 18, 2011
CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancerPeter Jo, Klaus Jung, Marian Grade, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Genes, Chromosomes & Cancer|November 10, 2017
Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgeryYue Hu, Jochen Gaedcke, Georg Emons, et al.
International Journal of Molecular Sciences|April 20, 2016
Prognostic Value of MicroRNAs in Preoperative Treated Rectal CancerAzadeh Azizian, Ingo Epping, Frank Kramer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2009
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapyJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Genes, Chromosomes & Cancer|August 21, 2010
Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomasJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 13, 2013
Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7gJunius Salendo, Melanie Spitzner, Frank Kramer, et al.
International Journal of Cancer|September 27, 2012
Molecular patterns in the evolution of serrated lesion of the colorectumTimo Gaiser, Sandra Meinhardt, Daniela Hirsch, et al.
Annals of Surgical Oncology|February 25, 2011
Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatmentLena-Christin Conradi, Annalen Bleckmann, Markus Schirmer, et al.
Plos One|October 1, 2020
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancerPeter Jo, Markus Bernhardt, Manuel Nietert, et al.
Plos One|April 12, 2016
Heterogeneity of KRAS Mutation Status in Rectal CancerPeter Jo, Alexander König, Markus Schirmer, et al.
Surgery|October 18, 2011
CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancerPeter Jo, Klaus Jung, Marian Grade, et al.
Pageof 3